Educate the brightest and best experts in Synthetic Biology about your business: what it is, what it does and why it matters.
Be part of our exhibition, situated at the nucleus of event activity – just outside the conference presentation rooms, an area designed to be at the core of meeting and networking activity.
Limited exhibitor opportunities are available. Please contact Dr John Collins, our exhibition manager, by following the link below to receive further details.
Evonetix is set to revolutionise de novo gene synthesis to facilitate the fast-growing and exciting field of synthetic biology. Our unique selling point is driven by high fidelity and parallelisation of gene synthesis. www.evonetix.com
At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. https://twistbioscience.com
With a portfolio of more than 4,000 products covering the fields of genomics, protein analysis and expression, cellular analysis, drug discovery and genetic identity, Promega is a global leader in providing innovative solutions and technical support to life scientists in academic, industrial and government settings.
Promega products are used by life scientists who are asking fundamental questions about biological processes as well as by scientists who are applying scientific knowledge to diagnose and treat diseases, discover new therapeutics, and use genetics and DNA testing for human identification. https://www.promega.co.uk
Integrated DNA Technologies, Inc. (IDT) is your Advocate for the Genomics Age. For more than 30 years, IDT's innovative tools and solutions for genomics applications have been driving advances that inspire scientists to dream big and achieve their next breakthroughs.
IDT develops, manufactures, and markets nucleic acid products that support the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics, and pharmaceutical development. We have a global reach with personalized customer service. https://www.idtdna.com/pages
Today, biologists spend too much time pipetting by hand. We think biologists should have robots to do pipetting for them. People doing science should be free of tedious benchwork and repetitive stress injuries. They should be able to spend their time designing experiments and analyzing data.
That's why we started Opentrons.
We make robots for biologists. Our mission is to provide the scientific community with a common platform to easily share protocols and reproduce each other's results. Our robots automate experiments that would otherwise be done by hand, allowing our community to spend more time pursuing answers to some of the 21st century’s most important questions. https://www.opentrons.com
BMG LABTECH is a leading global developer and manufacturer of innovative, high-quality, and reliable microplate reader instrumentation. BMG LABTECH has been committed to producing microplate readers for more than twenty-five years. By focusing on the needs of the scientific community, the company’s innovative microplate readers have earned the company the reputation of being a technology leader in the field. BMG LABTECH has developed a wide range of dedicated and multi-mode microplate readers for life sciences applications and high-throughput screening.
We, the Dispendix GmbH, are a spinoff of the Fraunhofer Institute for Manufacturing Engineering and Automation (IPA) in Stuttgart, Germany — and a part of the CELLINK Group. At IPA, a novel liquid-handling technology called I-DOT (“Immediate-Drop-On-Demand technology”) was developed to establish an efficient, flexible alternative non-contact solution for liquid-handling tasks for nano- to microliter volumes. Our vision is to establish a simple and elegant gold standard in non-contact liquid handling that is affordable for everyone. Our passion for simple and elegant solutions drives our motivation to create robust, reliable and precise solutions for nanoliter dispensing.
The UK Centre for Mammalian Synthetic Biology is a BBSRC/EPSRC/MRC Synthetic Biology Research Centre, hosted by the School of Biological Sciences at the University of Edinburgh. Our vision is to apply synthetic biology in mammalian systems to realise its full potential for human medicine.
With world-leading faculty members drawn from the Biological Sciences, Medicine, Engineering, Informatics and the Social Sciences, the Centre offers an exciting and collaborative research environment. It also embeds colleagues from the Scottish Centre for Regenerative Medicine, a centre of excellence for stem cell research, who are supervisors on several projects.
WISB delivers an integrated, internationally leading programme of research, innovation and training for synthetic biology. WISB is a BBSRC/EPSRC funded Synthetic Biology Research Centre (SBRC), supported through the UK Research Councils' Synthetic Biology for Growth programme.
The University of Manchester’s, Synthetic Biology Research Centre for Synthetic Biology of Fine and Speciality Chemicals (SYNBIOCHEM), funded by BBSRC/EPSRC aims to develop new faster, more predictable and reliable “greener” routes to fine and speciality chemicals production. The Centre provides tools, technology platforms and SynBio ‘know-how’ to drive academic discovery and translate new knowledge and processes towards industrial exploitation. The technology will lead to new products and methods for drug development, such as new antibiotics, and agricultural chemicals and new materials for sustainable manufacturing.
The SBRC-Nottingham is one of six synthetic biology research centres established by the UK Research councils BBSRC and EPSRC.
Our centre concentrates on engineering bacteria to make industrially-useful products from C1-feedstocks including the greenhouse gases, carbon monoxide and carbon dioxide and methane.
Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. The team of scientists works in different academic partner laboratories and R&D programs involve partners from Belgium, Brazil, France, Germany, The Netherlands, and the UK. Syngulon owns a collection of natural and synthetic bacteriocins. Syngulon is generating a patent portfolio of genetic technologies to solve key issues: Gene containment, Yield increase, Contamination prevention, Genetic drift and Antibiotic-free selection of expressing clone
Established in the mid 1970's, New England Biolabs, Inc. (NEB) is the industry leader in the discovery and production of enzymes for molecular biology applications and now offers the largest selection of recombinant and native enzymes for genomic research. NEB continues to expand its product offerings into areas related to PCR, gene expression, sample preparation for next-generation sequencing, synthetic biology, glycobiology, epigenetics and RNA analysis. Additionally, NEB is focused on strengthening alliances that enable new technologies to reach key market sectors, including molecular diagnostics development. New England Biolabs is a privately held company, headquartered in Ipswich, MA, and has extensive worldwide distribution through a network of exclusive distributors, agents and seven subsidiaries located in Canada, China, France, Germany, Japan, Singapore and the UK. For more information about New England Biolabs visit www.neb.com
The Knowledge Transfer Network (KTN) links new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From biotechnology to autonomous systems and from energy to design, KTN combines in-depth knowledge in all sectors with the ability to cross boundaries. KTN is a network partner of Innovate UK, helping to deliver UK economic growth.
KTN’s Synthetic Biology team focuses on partnering UK’s growing synthetic biology industry with industrial collaborators, research-base expertise and all relevant stakeholders, enabling cross-sector commercialisation.
As a partner in the KETBIO Biotech transfer project, KTN aims to identify Europe's most innovative results in biotechnology research, including synthetic biology and help to speed up their market uptake.
For detailed information on KTN please visit https://www.ktn-uk.co.uk